A phase 3 trial of the drug dichlorphenamide in hyperkalemic and hypokalemic periodic paralysis is open at several U.S. and European centers

posted on October 14, 2011 - 10:13am
A multicenter study of the drug dichlorphenamide in 140 adults with hyperkalemic or hypokalemic periodic paralysis is open at sites in California, Kansas, Massachusetts, Minnesota, Missouri, New York, Ohio and Texas, as well as in France (not yet recruiting), Italy and the United Kingdom. 
posted on October 1, 2011 - 10:09am
QUEST Vol. 18, No. 4
Featured in this update: Families, experts meet at BMD ConferenceThree trials study blood-vessel-dilating drugs in BMD, DMDResults of daily, weekly prednisone treatment about the same in DMD
posted on November 1, 2007 - 1:12pm
QUEST Vol. 14, No. 6
Items in this article refer to clinical trials in: Duchenne muscular dystrophy, myasthenia gravis, Becker muscular dystrophy, limb-girdle muscular dystrophy, hypokalemic and hyperkalemic periodic paralysis, Pompe disease, FSH muscular dystrophy,  Miyoshi distal muscular dystrophy, myotubular myopathy, congenital muscular dystrophy and ALS.